Gadoxetate Disodium |
Katalog-Nr.GC36100 |
Gadoxetat-Dinatrium (Gd-EOB-DTPA-Dinatrium) ist ein Kontrastmittel in der Magnetresonanztomographie (MRT) des hepatobiliÄren Systems, das sich in normalen, funktionierenden Hepatozyten anreichert. Gadoxetat-Dinatrium (Gd-EOB-DTPA-Dinatrium) wird verwendet, um fokale LeberlÄsionen wie hepatozellulÄres Karzinom oder Lebermetastasen in der T1-gewichteten Bildgebung zu beurteilen.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 135326-22-6
Sample solution is provided at 25 µL, 10mM.
Gadoxetate Disodium (Gd-EOB-DTPA Disodium) is a contrast agent in magnetic resonance imaging (MRI) of the hepatobiliary system, which accumulates in normal, functioning hepatocytes. Gadoxetate Disodium (Gd-EOB-DTPA Disodium) is used to evaluate focal liver lesions, such as hepatocellular carcinoma or liver metastasis on T1-weighted imaging[1][2][3].
[1]. Schuhmann-Giampieri G, et al. Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system. Radiology. 1992 Apr;183(1):59-64. [2]. Katsube T, et al. Estimation of liver function using T1 mapping on Gd-EOB-DTPA-enhanced magnetic resonance imaging. Invest Radiol. 2011 Apr;46(4):277-83. [3]. Saito K, et al. Gd-EOB-DTPA enhanced MRI for hepatocellular carcinoma: quantitative evaluation of tumor enhancement in hepatobiliary phase. Magn Reson Med Sci. 2005;4(1):1-9.
Average Rating: 5
(Based on Reviews and 28 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *